1. Germany Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Wacker Chemie AG

Wacker Chemie AG

WCH.DE
Wacker Chemie AGDE flagDeutsche Börse
105.60
EUR
+0.60
- -
5.25BMarket Cap
Wacker Chemie AG
WCH.DE
(Deutsche Börse)

Recent

price

105.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
95.58
98.83
93.3
90.16
97.15
106.61
93.28
99.12
100.22
99.19
94.45
124.95
165.25
128.87
115.18
110.42
109.12
Revenue per Share
10
7.1
2.43
0.05
4.1
4.97
3.61
17.45
4.95
-12.94
3.81
16.24
25.18
6.31
4.85
-16.53
-16.19
Basic EPS, GAAP
9.78
1.73
-11.67
-2.08
-0.8
-4.1
6.42
6.62
2.03
3.82
13.03
14.96
11.36
5.97
-7.21
-0.21
11.86
Free Cash Flow per Basic Share
1.2
3.2
2.2
0.6
0.5
1.5
2
2
4.5
2.5
0.5
2
8
12
3
2.5
- -
Dividend per Share
45.97
45.3
45.53
44.98
48.59
53.74
55.35
71.76
72.24
56.81
60.12
74.36
91.55
85.86
87.71
68.68
71.37
Book Value per Share
48.58
47.76
42.19
43.82
38.52
55.62
51.19
62.96
62.55
40.25
33.63
61.49
96.98
86.28
89.78
70.81
72.14
Tangible Book Value per Share
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
Basic Weighted Avg Shares
4,748
4,910
4,635
4,479
4,826
5,296
4,634
4,924
4,979
4,928
4,692
6,208
8,209
6,402
5,722
5,485
5,413
Sales/Revenue/Turnover
16.9
13.4
7.89
4.28
9.06
10.13
7.01
7.95
5.37
3.48
6.08
16.99
17.87
5.19
4.72
-1.58
-0.5
Operating Margin (%)
430
501
529
564
599
575
618
590
540
1,320
404
404
402
419
473
606
600
Depreciation Expense
497
353
121
3
204
247
179
867
246
-643
189
807
1,251
314
241
-821
-803
Net Income, GAAP
32.13
37.24
43.75
79.68
46.5
40.55
27.72
23.61
19.82
- -
7.16
24.31
20.7
15.43
- -
- -
40.47
Effective Tax Rate (%)
10.47
7.18
2.6
0.06
4.22
4.66
3.87
17.6
4.94
-13.04
4.03
13
15.24
4.9
4.21
-14.97
-14.83
Profit Margin (%)
961
1,120
796
887
928
812
707
1,273
1,354
1,596
2,202
2,136
2,733
2,139
2,444
2,623
2,658
Working Capital
- -
662
958
958
954
733
372
525
605
868
1,151
882
1,076
1,079
1,722
2,203
- -
LT Debt
2,447
2,403
2,121
2,197
1,946
2,795
2,593
3,169
3,146
2,029
1,692
3,100
5,031
4,580
4,837
3,756
3,816
Total Equity
24.3
14.45
6.28
1.16
7.07
8.96
6.22
7.87
5.47
- -
8.87
21.59
21.26
4.45
- -
- -
- -
Return on Invested Capital (%)
26.01
14.24
5.2
0.53
7.49
7.87
5.74
21.95
6.45
- -
5.46
17.58
22.77
6.04
- -
- -
-19.57
Return on Capital (%)
25.65
15.55
5.35
0.12
8.77
9.71
6.61
27.45
6.88
-20.05
6.51
24.15
30.36
7.12
5.59
-21.14
-19.96
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
151
- -
LT Borrowings
- -
1,926
- -
LT Finance Leases
- -
277
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
50
50
Market Capitalization
3,175
3,435
4,171

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
3,545
3,894
3,994
Cash, Cash Equivalents & STI
838
1,488
1,508
Accounts Receivable, Net
797
689
801
Inventories
1,622
1,439
1,442
Total Current Liabilities
1,173
1,270
1,336
Payables & Accruals
- -
- -
- -
ST Debt
- -
151
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.19%
23.96%
-22.36%
Free Cash Flow
-36.82%
-74.9%
-97.04%
Net Income, GAAP
-36.31%
-31.45%
-440.71%
Sales/Revenue/Turnover
1.68%
5.55%
-4.13%
Total Cash Common Dividend
- -
111.79%
-16.64%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,490
1,468
1,430
1,335
5,722
2025
1,478
1,413
1,340
1,254
5,485
2026
1,406
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.89
- -
0.56
- -
4.85
2025
-0.16
- -
-1.73
- -
-16.53
2026
0.21
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.4
- -
3
2025
- -
- -
0.25
- -
2.5
2026
- -
- -
- -
- -
- -
Similar Companies
Shalimar Paints Limited (SHALPAINTS.BO)
Itaconix plc (ITXXF)
Qualipoly Chemical Corp. (4722.TW)
Shin Foong Specialty and Applied Materials Co., Ltd. (6582.TW)
Aether Industries Limited (AETHER.NS)
PCC Exol S.A. (PCX.WA)
Business
Wacker Chemie AG manufactures specialty silicones, polymers, biosolutions, and polysilicon for applications in construction, automotive, electronics, healthcare, pharmaceuticals, consumer goods, and photovoltaics; its core offerings include silicone elastomers, fluids, resins, and sealants; polymer binders such as vinyl acetate-ethylene dispersions and redispersible polymer powders; biopharmaceutical services encompassing mRNA therapeutics, lipid nanoparticles, and plasmid DNA production; and hyperpure polysilicon alongside chlorosilanes and fumed silica for semiconductor and solar wafers. The company, founded in 1914 and headquartered in Munich, Germany, operates 27 production sites and 47 sales offices worldwide, supplying over 3,000 products to more than 100 countries with approximately 16,400 employees. Wacker Chemie maintains a subsidiary, Siltronic AG, focused on semiconductor wafers, and derives roughly 65% of sales from silicon-based products and 35% from ethylene- and acetic acid-based items, targeting industries including chemical processing, medical technology, and renewable energy. Recent developments include the 2024 acquisition of manufacturing assets and expertise from U.S.-based Bio Med Sciences Inc. to enhance silicone-coated healthcare products like wearable devices and scar care; completion of capacity expansions for specialty silicones at its Zhangjiagang, China site; opening of a new mRNA Competence Center in Halle, Germany; and ongoing investments to boost semiconductor-grade polysilicon production at Burghausen, Germany, with a new facility slated for 2025 that will increase capacity by over 50% and create more than 100 jobs. Capital expenditures reached €666 million in 2024, prioritizing growth across all divisions amid market challenges, as evidenced by Q3 2025 sales of €1.34 billion.